Jianqiang Zhu Selected Research

Neoplasms (Cancer)

4/2024	Tumor Supplying Artery Injection of Liposome@Sunitinib Could Effectively Inhibit the Progression of Kidney Tumor.
4/2024	ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
8/2023	Low-dose graphene oxide promotes tumor cells proliferation by activating PI3K-AKT-mTOR signaling via cellular membrane protein integrin αV.
1/2023	STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer.
1/2022	STIL Acts as an Oncogenetic Driver in a Primary Cilia-Dependent Manner in Human Cancer.
1/2022	Palladium Nanoplate-Based IL-6 Receptor Antagonists Ameliorate Cancer-Related Anemia and Simultaneously Inhibit Cancer Progression.
10/2021	Tumor-specific fluorescence activation of rhodamine isothiocyanate derivatives.
1/2020	Graphene Oxide Promotes Cancer Metastasis through Associating with Plasma Membrane To Promote TGF-β Signaling-Dependent Epithelial-Mesenchymal Transition.
1/2017	Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents.
12/2014	Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianqiang Zhu Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 12/2014
2	Carcinogenesis 04/2024 - 12/2023
2	Erectile Dysfunction 12/2023 - 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Breakthrough Infections 01/2023
1	Carcinoma (Carcinomatosis) 09/2022
1	Anemia 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Sudden Infant Death (SID) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Obesity 05/2019
1	Body Weight (Weight, Body) 05/2019
1	Thrombosis (Thrombus) 03/2016
1	Fibrosis (Cirrhosis) 01/2016

Drug/Important Bio-Agent (IBA)

3	graphene oxideIBA 08/2023 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2014
1	Sunitinib (Sutent)FDA Link 04/2024
1	Liposomes (Liposome)IBA 04/2024
1	Therapeutic UsesIBA 04/2024
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 04/2024
1	Tumor Biomarkers (Tumor Markers)IBA 04/2024
1	Phosphorus (Red Phosphorus)IBA 12/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2023
1	IntegrinsIBA 08/2023
1	Aurora Kinase AIBA 01/2023
1	Inactivated VaccinesIBA 01/2023
1	PalladiumIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	ThioureaIBA 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	rhodamine isothiocyanateIBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	GraphiteIBA 01/2020
1	FertilizersIBA 01/2020
1	NitrosaminesIBA 05/2019
1	Triglycerides (Triacylglycerol)IBA 05/2019
1	Drinking WaterIBA 05/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Protein CoronaIBA 03/2016
1	Immunoglobulin G (IgG)IBA 03/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016

Therapy/Procedure

4	Therapeutics 12/2023 - 01/2017
2	Radiotherapy 04/2024 - 01/2022
1	Drug Therapy (Chemotherapy) 04/2024
1	Intravenous Administration 04/2024
1	Urinary Diversion (Ileal Conduit) 09/2022
1	Cystectomy 09/2022
1	Aftercare (After-Treatment) 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2016